RNAi Creates Novel Court Filings; Tekmira In Trade Secrets Dispute With AlCana
Executive Summary
A British Columbia court orders AlCana to return thousands of documents it allegedly downloaded from Tekmira’s electronic document management system. The claim arose from Tekmira’s suit against Alnylam and AlCana alleging trade secrets theft.
You may also be interested in...
Alnylam Sheds Legal Trouble But Picks Up Manufacturing Challenge In Tekmira Settlement
Alnylam is paying Tekmira $65 million to resolve an RNAi trade secrets suit; the new licensing pact reduces Alnylam’s future milestone and royalty payments on three compounds and allows the firm to manufacture its own drug candidates.
Roche's Transfer Of Assets To Arrowhead May Create Most-Comprehensive RNAi Firm
After an expensive foray into RNAi, Roche is handing off its substantial portfolio to Arrowhead, in exchange for a 10% stake in the company and right-of-first-negotiation to programs and earn-out potential.
From Friends To Foes: Tekmira Slaps Partner Alnylam With Lawsuit
Suit alleges Alnylam stole Tekmira's RNAi delivery technology, but Alnylam dismisses the claims and says its delivery technology falls within its licensing agreement or other partnerships.